BIOMAT Database Logo BIOMAT Database Logo

The Nose Knows: Intranasal Midazolam To Treat Acute Seizures During Inpatient Epilepsy Monitoring. 2020

David G Vossler

[Box: see text].

UI MeSH Term Description Entries

Related Publications

David G Vossler
Use of intranasal midazolam to treat acute seizures in paediatric community settings.
January 2004, Journal of paediatrics and child health,
David G Vossler
Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures.
September 2015, Epilepsia,
David G Vossler
[Intranasal and buccal midazolam in the treatment of acute seizures].
January 2004, Revista de neurologia,
David G Vossler
Intranasal midazolam vs rectal diazepam in acute childhood seizures.
May 2006, Pediatric neurology,
David G Vossler
Intranasal midazolam for childhood seizures.
August 1998, Lancet (London, England),
David G Vossler
The Winner by a Nose: Intranasal Midazolam.
September 2019, Epilepsy currents,
David G Vossler
Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy.
August 2010, Archives of pediatrics & adolescent medicine,
David G Vossler
Treatment of acute seizures: is intranasal midazolam a viable option?
April 2013, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG,
David G Vossler
The IN-MIDAZ study - Intranasal midazolam in aborting seizures - An epilepsy monitoring unit based randomized controlled trial for efficacy.
December 2022, Epilepsy research,
David G Vossler
Intranasal midazolam for prolonged convulsive seizures.
September 2000, Brain & development,
Copied contents to your clipboard!